COVID-19 Vaccination Plans

Here is some information provided by the Greendale Health Department regarding COVID-19 vaccinations.
If you have any questions, you can call your area health department.
This is a link to the Health Departments that we have been in contact with. 

Centers for Disease Control and Prevention – Frequently Asked Questions about COVID-19 Vaccination

U.S. COVID-19 Vaccination Plans

  1. Many COVID-19 vaccine candidates are in development, and clinical trials are being conducted simultaneously with large-scale manufacturing. It is not known which vaccines will be authorized or approved. The CDC is planning for many possibilities.
  1. The safety of COVID-19 vaccines is a top priority.

 Existing data systems have validated analytic methods that can rapidly detect statistical signals for possible vaccine safety problems. These systems are being scaled up to fully meet the needs of the nation. Additional systems and data sources are also being developed to further enhance safety monitoring capabilities. 

  1. As a patient’s most trusted source of information about vaccines, you will play a critical role in helping build confidence in COVID-19 vaccination.

As you talk with patients, acknowledge the disruption COVID-19 has had on all our lives. This allows you to establish common concerns that can be addressed by vaccination. 

  1. At least at first, COVID-19 vaccines may be used under an Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA).
  1. Once FDA authorizes or approves use of COVID-19 vaccine(s), limited quantities will become available very quickly because of advance planning by the U.S. government and other entities.
  1. Limited COVID-19 vaccine doses may be available this year, but supply will increase substantially in 2021.
  1. If there is limited supply, some groups may be recommended to get a COVID-19 vaccine first.

ACIP will issue recommendations to CDC once a vaccine(s) is authorized or approved for use.

  1. All interested vaccination providers may not receive vaccines immediately. If there is a limited supply of COVID-19 vaccines, doses will likely be distributed to providers that serve groups identified to get vaccinated first. There will be an application and onboarding process for those interested in providing COVID-19 vaccines. There are specific logistical requirements, including requirements for vaccine storage and handling, product tracking, administration, and reporting.
  1. At first, COVID-19 vaccines may not be authorized, approved, or recommended for children. Only non-pregnant adults participated in early clinical trials for various COVID-19 vaccines.
  1. COVID-19 vaccine planning is being updated as new information becomes available.